ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
자궁 경부 이형성증 시장 규모는 2025년 22억 3,000만 달러에서 2034년에는 43억 5,000만 달러에 이를 것으로 예측되며, 2026-2034년 CAGR 7.72%로 성장할 전망입니다.
자궁경부 이형성증 시장은 자궁경부 건강에 대한 인식이 높아지고 여성의 자궁경부 이형성증 발생률이 증가함에 따라 괄목할만한 성장세를 보이고 있습니다. 자궁경부이형성증은 자궁경부의 비정상적인 세포 증식을 특징으로 하는 전암성 질환으로, 자궁경부암으로의 진행을 예방하기 위해서는 조기 발견과 개입이 필수적입니다. 의료진과 환자들이 예방 의료와 조기 진단을 중시하는 가운데, 자궁경부 이형성증 검진 및 치료 옵션에 대한 수요가 급증하고 있습니다. HPV 검사, 첨단 영상진단 기술 등 진단기술의 혁신으로 자궁경부이형성증의 검출 정확도와 효율성이 향상되고 있습니다.
또한, 여성의 건강과 웰빙에 대한 관심이 높아지면서 자궁경부 이형성증 시장에 큰 영향을 미치고 있습니다. 정기적인 검진 및 백신 접종의 중요성을 알리는 홍보 및 교육 프로그램을 통해 예방 의료 서비스를 찾는 여성들이 증가하고 있습니다. HPV 백신과 같은 백신의 보급 확대도 자궁경부 이형성증 사례 감소에 기여하고 있으며, 관련 의료 서비스 및 제품에 대한 수요를 더욱 촉진하고 있습니다.
또한, 연구개발의 발전도 자궁경부 이형성증 시장에 긍정적인 영향을 미칠 것으로 예측됩니다. 자궁경부 이형성증의 근본 원인과 관련 위험 요인에 대한 지속적인 연구가 새로운 치료 옵션과 치료 접근법의 길을 열어가고 있습니다. 의료진, 연구자, 제약사 간의 협력 강화로 자궁경부 이형성증으로 고통받는 여성들의 니즈를 충족시킬 수 있는 혁신적인 솔루션 개발이 촉진되고 있습니다. 시장이 계속 진화하는 가운데, 교육, 예방, 기술 혁신에 대한 집중은 자궁경부 이형성증 분야의 괄목할 만한 성장을 견인할 것입니다.
목차
제1장 서론
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 자궁 경부 이형성증 시장 : 유형별
제5장 세계의 자궁 경부 이형성증 시장 : 진단 방법별
제6장 세계의 자궁 경부 이형성증 시장 : 치료법별
제7장 세계의 자궁 경부 이형성증 시장 : 최종사용자별
제8장 세계의 자궁 경부 이형성증 시장 : 지역별
제9장 경쟁 구도
제10장 기업 개요
LSH
영문 목차
영문목차
The Cervical Dysplasia Market size is expected to reach USD 4.35 Billion in 2034 from USD 2.23 Billion (2025) growing at a CAGR of 7.72% during 2026-2034.
The Cervical Dysplasia market is experiencing notable growth, driven by the increasing awareness of cervical health and the rising incidence of cervical dysplasia among women. Cervical dysplasia, a precancerous condition characterized by abnormal cell growth on the cervix, necessitates early detection and intervention to prevent the progression to cervical cancer. As healthcare providers and patients prioritize preventive care and early diagnosis, the demand for screening and treatment options for cervical dysplasia is surging. Innovations in diagnostic technologies, such as HPV testing and advanced imaging techniques, are enhancing the accuracy and efficiency of cervical dysplasia detection.
Moreover, the growing emphasis on women's health and wellness is significantly influencing the Cervical Dysplasia market. As awareness campaigns and educational initiatives promote the importance of regular screenings and vaccinations, more women are seeking preventive care services. The increasing availability of vaccines, such as the HPV vaccine, is also contributing to the reduction of cervical dysplasia cases, further driving the demand for related healthcare services and products.
Additionally, advancements in research and development are likely to benefit the Cervical Dysplasia market. Ongoing studies into the underlying causes and risk factors associated with cervical dysplasia are paving the way for new treatment options and therapeutic approaches. The increasing collaboration between healthcare providers, researchers, and pharmaceutical companies is fostering the development of innovative solutions that address the needs of women affected by cervical dysplasia. As the market continues to evolve, the focus on education, prevention, and technological innovation will drive significant growth in the Cervical Dysplasia sector.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Type
Low-Grade Cervical Dysplasia
High-Grade Cervical Dysplasia
By Diagnostic Method
Pap Smear Test
HPV Test
Colposcopy
Biopsy
Others
By Treatment
Surgical
Non-Surgical
By End-User
Hospitals
Specialty Clinics
Diagnostic Centers
Others
COMPANIES PROFILED
Hologic Inc, F HoffmannLa Roche Ltd, Qiagen NV, Becton, Dickinson and Company, Abbott Laboratories, Quest Diagnostics Incorporated, OncoHealth Corporation, Zilico Ltd, CooperSurgical Inc, DYSIS Medical Ltd, Lumenis Ltd, Philips Healthcare, Medtronic plc, Siemens Healthineers AG, GE Healthcare
We can customise the report as per your requriements
TABLE OF CONTENTS
Chapter 1. PREFACE
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1 Information Analysis
1.3.2 Market Formulation & Data Visualization
1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
3.4.1 Standards & Compliance
3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
3.5.1 Market Drivers
3.5.2 Market Restraints
3.5.3 Market Opportunities
3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis
Chapter 4. GLOBAL CERVICAL DYSPLASIA MARKET: BY TYPE 2022-2034 (USD MN)
4.1. Market Analysis, Insights and Forecast Type
4.2. Low-Grade Cervical Dysplasia Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. High-Grade Cervical Dysplasia Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL CERVICAL DYSPLASIA MARKET: BY DIAGNOSTIC METHOD 2022-2034 (USD MN)
5.1. Market Analysis, Insights and Forecast Diagnostic Method
5.2. Pap Smear Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. HPV Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Colposcopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL CERVICAL DYSPLASIA MARKET: BY TREATMENT 2022-2034 (USD MN)
6.1. Market Analysis, Insights and Forecast Treatment
6.2. Surgical Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Non-Surgical Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL CERVICAL DYSPLASIA MARKET: BY END-USER 2022-2034 (USD MN)
7.1. Market Analysis, Insights and Forecast End-user
7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL CERVICAL DYSPLASIA MARKET: BY REGION 2022-2034(USD MN)
8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.2.1 By Type
8.2.2 By Diagnostic Method
8.2.3 By Treatment
8.2.4 By End-user
8.2.5 United States
8.2.6 Canada
8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.3.1 By Type
8.3.2 By Diagnostic Method
8.3.3 By Treatment
8.3.4 By End-user
8.3.5 United Kingdom
8.3.6 France
8.3.7 Germany
8.3.8 Italy
8.3.9 Russia
8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.4.1 By Type
8.4.2 By Diagnostic Method
8.4.3 By Treatment
8.4.4 By End-user
8.4.5 India
8.4.6 Japan
8.4.7 South Korea
8.4.8 Australia
8.4.9 South East Asia
8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.5.1 By Type
8.5.2 By Diagnostic Method
8.5.3 By Treatment
8.5.4 By End-user
8.5.5 Brazil
8.5.6 Argentina
8.5.7 Peru
8.5.8 Chile
8.5.9 South East Asia
8.5.10 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.6.1 By Type
8.6.2 By Diagnostic Method
8.6.3 By Treatment
8.6.4 By End-user
8.6.5 Saudi Arabia
8.6.6 UAE
8.6.7 Israel
8.6.8 South Africa
8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL CERVICAL DYSPLASIA INDUSTRY
